Global Prefilled Saline Flush Syringes Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030
Prefilled saline flush syringes are single-use syringes filled with sterile saline solution in various volumes, which are used to help prevent vascular access systems blockage and clear any medication that may be left at the catheter site. Prefilled saline flush syringes are filled with sterile saline, helping to reduce medication errors and contamination risks associated with multi-dose vials. Prefilled saline flush syringes also improve clinician efficiency and workflow by eliminating the steps and time involved in the manual preparation of saline syringes, and they are available in a variety of sizes. The companies involved in the prefilled saline flush syringes market are primarily engaged in the development, manufacturing, and marketing of prefilled saline flush syringe products.
Market Overview:The latest research study on the global Prefilled Saline Flush Syringes market finds that the global Prefilled Saline Flush Syringes market reached a value of USD 592.23 million in 2023. It’s expected that the market will achieve USD 962.66 million by 2029, exhibiting a CAGR of 8.43% during the forecast period.
Outstanding advantages
The powerful functions and benefits of prefilled saline flush syringe drive consumption, which is beneficial to the development of the industry. Pre-filled syringes have been an integral part of the rapid advancements in the healthcare industry. These syringes have not only ensured easy drug delivery but also reduced the safer administration of drugs. The usage of prefilled syringes has ensured a lesser number of needle stick injuries as they eliminate the hassle of preparing dosages. The biggest advantage of prefilled saline flush syringe is that it prevents contamination as it reduces the chances of solution touching or entering the non-sterile parts of the syringe.
Safety concerns
Because prefilled saline flush syringes are perceived as a commodity, and their use by providers is routine, procurement departments may place orders for prefilled saline flush syringes without adequate interdisciplinary review, assuming that all prefilled saline syringes are the same and, therefore, sterile and safe. They are perceived as low-risk, low-liability devices. Tragically, the evidence suggests otherwise.
Region Overview:In 2022, the share of the Prefilled Saline Flush Syringes market in North America stood at 40.14%.
Company Overview:Becton, Dickinson and Company
Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture, and sale of medical devices, instrument systems, and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.
B. Braun Medical Inc
B. Braun Medical, Inc. manufactures medical products. The Company offers admixture, dialysis, infusion therapy, duplex and premixed drugs, infusion pump systems, needle-free systems, and pain management products.
Becton, Dickinson and Company is one of the major players operating in the Prefilled Saline Flush Syringes market, holding a share of 36.93% in 2023.
Segmentation Overview:Among different product types,3ml Syringe Size segment is anticipated to contribute the largest market share in 2028.
Application Overview:By application, the Hospital segment occupied the biggest share from 2018 to 2022.
Key Companies in the global Prefilled Saline Flush Syringes market covered in Chapter 3:McKesson Corporation
Medefil
DBM
Amsino International Inc
SteriCare Solutions
Medline Industries, Inc
Cardinal Health
Weigao Group
Becton, Dickinson and Company
MedXL
Aquabiliti
Pentaferte Company
B. Braun Medical Inc
Nipro Corporation
In Chapter 4 and Chapter 14.2, on the basis of types, the Prefilled Saline Flush Syringes market from 2019 to 2030 is primarily split into:3ml Syringe Size
5ml Syringe Size
10ml Syringe Size
Other Size
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Prefilled Saline Flush Syringes market from 2019 to 2030 covers:Hospital
Intensive Care (IC)
Clinic
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)